Inflammatory Skin Diseases Drug Development Pipeline Review, 2018; New Report Launched
Inflammatory Skin Diseases Drug Development Pipeline Review, 2018 report provides an overview of the pipeline landscape for inflammatory skin disorders and comprehensive information on the therapeutics under development and key players involved in therapeutic development for acne vulgaris, rosacea and chronic urticaria (also known as hives). It also features dormant and discontinued products.
View full press release